4.5 Article

Clinical predictors of frequent exacerbations in subjects with severe chronic obstructive pulmonary disease (COPD)

Journal

RESPIRATORY MEDICINE
Volume 105, Issue 4, Pages 588-594

Publisher

W B SAUNDERS CO LTD
DOI: 10.1016/j.rmed.2010.11.015

Keywords

COPD acute exacerbations; COPD epidemiology; Risk factors for acute exacerbations of COPD

Funding

  1. Merck
  2. NIH
  3. GlaxoSmithKline
  4. AstraZeneca

Ask authors/readers for more resources

Background: Acute exacerbations are a significant source of morbidity and mortality associated with chronic obstructive pulmonary disease. Among individuals with COPD, some patients suffer an inordinate number of exacerbations while others remain relatively protected. We undertook a study to determine the clinical factors associated with frequent exacerbator status within a population of subjects with severe COPD. Methods: Case-control cohort recruited from two Boston-area practices. All subjects had GOLD stage 3 or 4 (FEV1 <= 50% predicted) COPD. Frequent exacerbators (n = 192) had an average of >= 2 moderate-to-severe exacerbations per year while non-exacerbators (n = 153) had no exacerbations in the preceding 12 months. Multivariate logistic regression was performed to determine the significant clinical predictors of frequent exacerbator status. Results: Physician-diagnosed asthma was a significant predictor of frequent exacerbations. Within a subset of our cohort, the modified Medical Research Council dyspnea score and FEF25-75% predicted were also significant clinical predictors of frequent exacerbator status (p < 0.05). Differences in exacerbation frequency were not found to be due to increased current tobacco use or decreased rates of maintenance medication use. Conclusions: Within our severe COPD cohort, a history of physician-diagnosed asthma was found to be a significant clinical predictor of frequent exacerbations. Although traditional risk factors such as decreased FEV1% predicted were not significantly associated with frequent exacerbator status, lower mid-expiratory flow rates, as assessed by FEF25-75% predicted, were significantly associated with frequent exacerbations in a subset of our cohort. (c) 2010 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available